申请人:LILLY S.A.
公开号:EP0297697A1
公开(公告)日:1989-01-04
Compounds of the following formula have pharmaceutical properties:
in which R¹ and R² independently are hydrogen, halo, nitro, amino, C₂₋₅ acylamino, C₁₋₄ alkyl, C₁₋₄ alkoxy, C₁₋₄ alkylthio, C₁₋₄ alkylsulphonyl, N-substituted heterocyclyl, optionally substituted phenyl, optionally substituted phenylthio, optionally substituted phenylsulphonyl or optionally substituted phenylsulphonamido, or R¹ and R² together form a C₃₋₅ alkylene bridge, R³ is C₁₋₄ alkyl or C₂₋₄ alkenyl, and X is (i) -(CH₂)nN(R⁴)₂ where each R⁴ independently is C₁₋₄ alkyl, C₂₋₄ alkenyl or optionally substituted C₆H₅CH₂-, and n is 1, 2 or 3, or (ii) a 5- to 8-membered alicyclic group containing one or two nitrogen atoms and directly attached to the amido nitrogen or attached by a C₁₋₃ alkylene chain; and salts thereof.
下式化合物具有药物特性:
其中 R¹ 和 R² 独立地为氢、卤素、硝基、氨基、C₂₋₅酰氨基、C₁₋₄ 烷基、C₁₋₄ 烷氧基、C₁₋₄ 烷硫基、C₁₋₄ 烷磺酰基、N-取代杂环基、任选取代的苯基、任选取代的苯硫基、任选取代的苯磺酰基或任选取代的苯磺酰胺基,或 R¹ 和 R² 共同形成 C₃₋₅ 亚烷基桥、R³ 是 C₁₋₄ 烷基或 C₂₋₄ 烯基,且 X 是 (i) -(CH₂)nN(R⁴)₂ 其中每个 R⁴ 独立地是 C₁₋₄ 烷基、C₂₋₄ 烯基或任选取代的 C₆H₅CH₂-、且 n 为 1、2 或 3,或 (ii) 包含一个或两个氮原子并直接连接至氨基氮或通过 C₁₋₃ 亚烷基链连接的 5 至 8 元脂环基团;及其盐类。